Position in ELAN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$19,273,746
+$11,747,599 QoQ
Shares Held
805,422
+142.2% QoQ
Ownership
0.161%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 98.99593008385666.ToString("F0")%
Shared 0.ToString("F0")%
None 1.0040699161433386.ToString("F0")%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Derivatives in ELAN
reported options exposure · as of Dec 31, 2022CallValue
$0
CallShares
0
PutValue
$1,833,000
PutShares
150,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $924,834,595 across 59 Drug Manufacturers - Specialty & Generic names. ELAN ranks #6 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,491,173 | $649,111,558 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
77,138 | $45,741,289 | |
| 3 | HLN |
Haleon plc
|
4,022,749 | $40,267,716 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
231,311 | $30,472,908 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,136,022 | $21,039,125 | |
| 6 | ELAN |
Elanco Animal Health Inc
This page
|
805,422 | $19,273,746 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
300,133 | $17,788,881 | |
| 8 | VTRS |
Viatris Inc
|
1,160,097 | $15,672,908 |
All Filings in ELAN
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,273,746 | 805,422 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $7,526,147 | 332,574 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $6,623,943 | 328,895 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,099,544 | 217,055 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,352,334 | 224,032 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,656,484 | 219,363 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,178,480 | 284,444 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,339,865 | 231,453 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,982,250 | 183,185 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $2,129,640 | 142,929 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,547,207 | 137,652 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,350,508 | 233,649 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $2,198,865 | 233,922 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,706,165 | 221,454 | Shares | Defined | 2023-02-13 | |
| 2022-12-31 | $1,833,000 | 150,000 | Put | Defined | 2023-02-13 | |
| 2022-09-30 | $4,523,158 | 364,477 | Shares | Defined | 2022-11-14 | |
| 2022-09-30 | $1,861,500 | 150,000 | Put | Defined | 2022-11-14 | |
| 2022-06-30 | $40,079,786 | 2,041,762 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $55,589,700 | 2,130,690 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $38,208,645 | 1,346,323 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $72,042,792 | 2,259,103 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $52,906,342 | 1,525,118 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $65,734,253 | 2,232,063 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $95,991,884 | 3,129,830 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $46,197,391 | 1,654,042 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $5,836,545 | 272,100 | Call | Defined | 2020-08-13 | |
| 2020-06-30 | $31,626,543 | 1,474,431 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $89,328,103 | 3,989,643 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||